Medicare Enrolled

Dr. Rajinikanth Ayyathurai, M.D

Urology Physician · Inverness, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Mixed engagement
609 W HIGHLAND BLVD, Inverness, FL 34452
3527269707
In practice since 2008 (18 years)
NPI: 1700058351 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ayyathurai from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ayyathurai? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ayyathurai

Dr. Rajinikanth Ayyathurai is an urology physician in Inverness, FL, with 18 years in practice. Based on federal Medicare data, Dr. Ayyathurai performed 13,892 Medicare services across 4,145 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ayyathurai received a total of $14,168 from 53 pharmaceutical and/or device companies across 260 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ayyathurai is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 9% volume in FL$ $14,168 industry payments

Medicare Practice Summary

Medicare Utilization ↗
13,892
Medicare services
Top 9% in FL for urology physician
4,145
Unique beneficiaries
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~772 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, degarelix, 1 mg5,120$3$8
Automated urinalysis1,856$2$5
Denosumab injection (Prolia/Xgeva)1,260$19$42
Office visit, established patient (30-39 min)925$94$320
Bladder ultrasound after voiding900$8$26
Office visit, established patient (20-29 min)756$64$227
Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml571$1$3
Blood draw (venipuncture)477$6$6
New patient office visit (45-59 min)269$121$422
Chronic care management, first 20 min/month252$48$159
Diagnostic exam of bladder and urethra using an endoscope213$61$207
Leuprolide acetate (for depot suspension), 7.5 mg147$135$336
Ultrasound scan of pelvic region through rectum98$25$82
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle95$24$81
Ceftriaxone antibiotic injection86$0$1
Simple timed assessment of bladder emptying74$10$33
Mri scan of pelvis before and after contrast69$139$360
Mri scan of pelvis without contrast65$95$247
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes59$67$256
Insertion of stent in ureter using an endoscope54$110$436
Drug injection, under skin or into muscle50$11$35
Instillation of anti-cancer drug into bladder49$68$219
Imaging of urinary tract following injection of a contrast agent42$20$170
Hospital follow-up visit, low complexity39$40$98
Initial hospital admission, moderate complexity35$101$341
New patient office visit (30-44 min)34$78$283
Biopsy of prostate gland33$102$333
Biopsy of bladder using an endoscope29$96$366
Office visit, established patient (10-19 min)29$34$142
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope27$565$1,866
Dilation of urethra using an endoscope24$123$380
Crushing of stone of ureter with insertion of stent using an endoscope23$343$1,084
Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm17$151$523
Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope16$123$386
Destruction of tissue of bladder, urethra, or surrounding glands using an endoscope15$134$450
Insertion of temporary bladder tube14$36$114
New patient office or other outpatient visit, 15-29 minutes13$49$183
Injection procedure to cause erection12$67$221
Office visit, established patient, complex (40-54 min)12$136$454
Complex measurement of pressure of urine flow in bladder with voiding pressure studies11$286$920
Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings11$26$162
Insertion of device into abdomen with pressure and urine flow rate study11$150$489
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.7% high complexity
60.7% medium
38.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,168
Total received (2018-2024)
Avg $2,024/year across 7 years
Top 15% in FL for urology physician
53
Companies
260
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,994 (49.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,680 (26.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,494 (24.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,483
2023
$1,412
2022
$4,320
2021
$617
2020
$839
2019
$1,786
2018
$3,711

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Scientific Affairs, LLC
$3,494
Intuitive Surgical, Inc.
$3,030
Medtronic USA, Inc.
$1,106
Astellas Pharma US Inc
$916
NeoTract Inc.
$583
Dendreon Pharmaceuticals LLC
$530
Janssen Biotech, Inc.
$519
PFIZER INC.
$510
Bayer Healthcare Pharmaceuticals Inc.
$428
Myriad Genetic Laboratories, Inc.
$372
Axonics, Inc.
$330
Cook Incorporated
$250
Teleflex LLC
$170
Endo Pharmaceuticals Inc.
$154
PROCEPT BioRobotics Corporation
$136
Bayer HealthCare Pharmaceuticals Inc.
$94
Medtronic, Inc.
$92
Merck Sharp & Dohme LLC
$90
Endo USA, Inc.
$80
180 Medical, Inc.
$77
Blue Earth Diagnostics Limited
$75
Sumitomo Pharma America, Inc.
$74
Sun Pharmaceutical Industries Inc.
$69
Boston Scientific Corporation
$68
Tempus AI, Inc
$68
UROGEN PHARMA, INC.
$66
Tolmar, Inc.
$63
Amgen Inc.
$57
TOLMAR Pharmaceuticals, Inc.
$55
Myovant Sciences Inc.
$47
Rochester Medical Corporation
$47
Edap Technomed Inc
$45
Olympus America Inc.
$44
Cook Medical LLC
$44
C. R. Bard, Inc. & Subsidiaries
$36
Coloplast Corp
$32
Progenics Pharmaceuticals, Inc.
$32
ACCORD HEALTHCARE, INC.
$25
Laborie Medical Technologies Corp.
$25
UroGen Pharma, Inc.
$24
Ferring Pharmaceuticals Inc.
$24
Avadel Specialty Pharmaceuticals, LLC
$22
SANOFI-AVENTIS U.S. LLC
$20
Merck Sharp & Dohme Corporation
$18
CONMED Corporation
$17
AstraZeneca Pharmaceuticals LP
$16
Amarin Pharma Inc.
$14
PROGENICS PHARMACEUTICALS, INC.
$14
DENTSPLY IH AB
$14
AbbVie, Inc.
$14
Telix Pharmaceuticals
$14
DENTSPLY IH Inc.
$12
Allergan, Inc.
$12
Top 3 companies account for 53.9% of total payments
Associated products mentioned in payments ›
AIRSEAL · AMS 700 · AQUABEAM ROBOTIC SYSTEM · AVEED · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · Bard Urinary Drainage Bag · Bulkamid · CAMCEVI · CAPTURA PRO · CHANTIX · Da Vinci Surgical System · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · GEMTESA · GENERAL BPH · ILLUCCIX · INTERSTIM · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · LoFric · Lunderquist · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · Prolia · SOLESTA · SOLIQUA · SPEEDICATH · SpaceOAR VUE System - 10mL · TITAN · TOVIAZ · URETERO-RENO VIDEOSCOPE · UroLift · UroLift System · Vascepa · XIAFLEX · XTANDI · Xofigo · Xtandi · YONSA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (49%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $102 per 100 Medicare services performed
Looking for a urology physician in Inverness?
Compare urology physicians in the Inverness area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology Physicians within 10 mi
15
Per 100K population
9.5
County median income
$55,355
Nearest hospital
HCA FLORIDA CITRUS HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Ayyathurai is a clinical cardiology specialist, with above-average Medicare volume (top 9% in FL), and high industry engagement (mixed engagement, top 15%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Ayyathurai experienced with injection, degarelix, 1 mg?
Based on Medicare claims data, Dr. Ayyathurai performed 5,120 injection, degarelix, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ayyathurai receive payments from pharmaceutical companies?
Yes. Dr. Ayyathurai received a total of $14,168 from 53 companies across 260 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ayyathurai's costs compare to other urology physicians in Inverness?
Dr. Ayyathurai's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ayyathurai) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →